BridgeMD
New treatment option for Lymphedema of Upper Limb
Official title Auto-Adjustable MOBIDERm Autofit Armsleeve in the Management of Upper Limb Lymphedema.
ClinicalTrials.gov ID: NCT06264817
What this study is testing
- What it's testing
- This study aims to assess Auto-Adjustable MOBIDERM® Autofit Armsleeve effect on upper limb volume excess compared to the compression bandages to manage the volume of upper limb lymphedema in patients with breast cancer related lymphedema
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Unilateral secondary upper limb lymphedema of stage II or III according to the criteria defined by the International Society of Lymphology, following...
- Volume difference between affected and healthy arm ≥ 10%
- Affected arm that fits with one of the 6 standard sizes of the Auto- Adjustable MOBIDERM Autofit armsleeve provided.
- Signed informed consent prior to any study-mandated procedure.
You likely can't join if
- Stage I lymphedema or located in several places.
- Patients for whom compression is contraindicated.
- Lymphedema associated with active cancer needing acute chemotherapy or having recurrence or metastasis.
- Motor and sensitive neurological deficiency / psychiatric or addictive disorders
- Pregnant or breastfeeding patient
- Patient intolerant to MOBIDERM Autofit or known allergies to the components used.
See the full eligibility criteria
- Unilateral secondary upper limb lymphedema of stage II or III according to the criteria defined by the International Society of Lymphology, following breast cancer
- Volume difference between affected and healthy arm ≥ 10%
- Affected arm that fits with one of the 6 standard sizes of the Auto- Adjustable MOBIDERM Autofit armsleeve provided.
- Signed informed consent prior to any study-mandated procedure.
- Stage I lymphedema or located in several places.
- Patients for whom compression is contraindicated.
- Lymphedema associated with active cancer needing acute chemotherapy or having recurrence or metastasis.
- Motor and sensitive neurological deficiency / psychiatric or addictive disorders
- Pregnant or breastfeeding patient
- Patient intolerant to MOBIDERM Autofit or known allergies to the components used.
- Participation to any other clinical study which has an impact on the different endpoints
- Vulnerable patient, adults being the object of a legal protective measure or enable to express their consent.
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.